Daiichi Sankyo Obtains Approval in Japan for Additional Indication and Dosage for Ovisot® for Injection in Diagnosis of Vasospastic Angina – Media & Investors Daiichi Sankyo O Saturday August 26th, 2017By Tokio X'press JPN, Pharmaceutical Daiichi Sankyo O